4.7 Review

Noncoding RNAs in acute kidney injury

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 234, 期 3, 页码 2266-2276

出版社

WILEY
DOI: 10.1002/jcp.27203

关键词

acute kidney injury; biomarker; circRNA; exosome; inflammation; lncRNA; microRNA; programmed cell death

资金

  1. National Natural Science Foundation of China [81570623, 81300580]
  2. Science and Technological Fund of Anhui Province for Outstanding Youth of China [1608085J07]

向作者/读者索取更多资源

Acute kidney injury (AKI), caused by various stimuli including ischemia reperfusion, nephrotoxic insult, and sepsis, is characterized by abrupt decline of kidney function. Till now, the molecular mechanisms for AKI have not been fully explored and the effective therapies are still lacking. Noncoding RNAs (ncRNAs), a group of biomolecules function at RNA level, are involved in a wide range of physiopathological processes including AKI. MicroRNAs (miRNAs) are the most extensively studied ncRNAs in AKI. Evidence indicated that miRNAs are altered significantly in various types of AKI. Gain-and-loss-of-function studies demonstrated that miRNAs, such as miR-24, miR-126, miR-494, and miR-687, may bind to the 3 '-untranslated region of their target genes to regulate inflammation, programmed cell death, and cell cycle in the injury and repair stages of AKI, indicating their therapeutic potential in AKI. In contrast, functions of long noncoding RNAs and circular RNAs in AKI are hot topics but still largely unknown. Additionally, ncRNAs packaged in exosome can be detected in circulation and urine, they may serve as specific biomarkers for AKI. This review summarized the alteration and functional role of ncRNAs and their therapeutic potential in AKI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Plant Sciences

7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation

Wei-Feng Wu, Jia-Nan Wang, Zeng Li, Biao Wei, Juan Jin, Li Gan, Hai-Di Li, Jun Li, Hai-Yong Chen, Xiao-Ming Meng

PHYTOMEDICINE (2020)

Review Pharmacology & Pharmacy

Potential therapeutic targets and promising drugs for combating SARS-CoV-2

Hong Zhou, Yan Fang, Tao Xu, Wei-Jian Ni, Ai-Zong Shen, Xiao-Ming Meng

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Review Cell Biology

Circular RNA in renal diseases

Juan Jin, Haolu Sun, Chao Shi, Hui Yang, Yiwan Wu, Wanhai Li, Yu-hang Dong, Liang Cai, Xiao-ming Meng

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production

Jia-Nan Wang, Qin Yang, Chen Yang, Yu-Ting Cai, Tian Xing, Li Gao, Fang Wang, Xin Chen, Xue-Qi Liu, Xiao-Yan He, Biao Wei, Ling Jiang, Chao Li, Juan Jin, Jia-Gen Wen, Tao-Tao Ma, Hai-Yong Chen, Jun Li, Xiao-Ming Meng

REDOX BIOLOGY (2020)

Article Pharmacology & Pharmacy

Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy

Xue-qi Liu, Juan Jin, Zeng Li, Ling Jiang, Yu-hang Dong, Yu-ting Cai, Ming-fei Wu, Jia-nan Wang, Tao-tao Ma, Jia-gen Wen, Ming-ming Liu, Jun Li, Yong-gui Wu, Xiao-ming Meng

BIOCHEMICAL PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury

Ju-Tao Yu, Xiao-Wei Hu, Hai-Yong Chen, Qin Yang, Hai-Di Li, Yu-Hang Dong, Yao Zhang, Jia-Nan Wang, Juan Jin, Yong-Gui Wu, Jun Li, Jin-Fang Ge, Xiao-Ming Meng

Summary: Alcohol consumption increases the risk of kidney injury by activating NLRP3 inflammasomes and NF-κB signaling, leading to inflammation. FTO epigenetically modifies PPAR-α through demethylation, resulting in renal inflammation.

PHARMACOLOGICAL RESEARCH (2021)

Review Cell Biology

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Hong Zhou, Wei-Jian Ni, Xiao-Ming Meng, Li-Qin Tang

Summary: miRNAs play pivotal roles in the inflammatory and immune processes of DN, affecting the progression of the disease by modulating various aspects of immune and inflammatory responses. Understanding the mechanisms and signaling pathways of miRNAs can lead to the identification of new therapeutic targets and strategies for the treatment of DN.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Plant Sciences

Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation

Qin Yang, Hong-mei Zang, Tian Xing, Shao-fei Zhang, Chao Li, Yao Zhang, Yu-hang Dong, Xiao-wei Hu, Ju-tao Yu, Jia-gen Wen, Juan Jin, Jun Li, Ren Zhao, Tao-tao Ma, Xiao-ming Meng

Summary: Gyp XLIX exerts significant renal protective effects in AKI by inhibiting renal dysfunction and alleviating inflammation and cell death. Mechanistically, Gyp XLIX mediates its effects by suppressing IGFBP7 levels and activating downstream signaling through the IGF1R kinase. These findings provide new insights for the potential clinical application of Gyp XLIX in AKI treatment.

PHYTOMEDICINE (2021)

Article Urology & Nephrology

Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism

Qin Yang, Li Gao, Xiao-wei Hu, Jia-nan Wang, Yao Zhang, Yu-hang Dong, Hui Yao Lan, Xiao-ming Meng

Summary: This study investigated the role of Smad3 in cisplatin-induced acute kidney injury, showing that disruption of Smad3 attenuated kidney injury, inflammation, and oxidative stress. Smad3-targeted therapy protected against loss of renal function, apoptosis, necroptosis, inflammation, and oxidative stress in cisplatin nephropathy, suggesting Smad3 as a potential therapeutic target for acute kidney injury.

KIDNEY DISEASES (2021)

Article Chemistry, Multidisciplinary

Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis

Fang Wang, Jia-nan Wang, Xiao-yan He, Xiao-guo Suo, Chao Li, Wei-jian Ni, Yu-ting Cai, Yuan He, Xin-yun Fang, Yu-hang Dong, Tian Xing, Ya-ru Yang, Feng Zhang, Xiang Zhong, Hong-mei Zang, Ming-ming Liu, Jun Li, Xiao-ming Meng, Juan Jin

Summary: The study demonstrates that SFN enhances programmed cell death and inflammation caused by cisplatin or I/R via interacting with RIPK3, suggesting it may serve as a promising therapeutic target for AKI treatment.

ACTA PHARMACOLOGICA SINICA (2022)

Article Biotechnology & Applied Microbiology

METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy

Ling Jiang, Xueqi Liu, Xueru Hu, Li Gao, Hanxu Zeng, Xian Wang, Yuebo Huang, Wei Zhu, Jianan Wang, Jiagen Wen, Xiaoming Meng, Yonggui Wu

Summary: Epigenetic changes, specifically the N-6-methyladenosine (m6A) modification, play a crucial role in diabetic nephropathy (DN). This study demonstrates that METTL3-mediated m6A modification is an important mechanism in podocyte injury in DN. Elevated METTL3 levels lead to increased inflammation and apoptosis, while METTL3 knockout alleviates these responses. Silencing METTL3 shows therapeutic potential in mitigating kidney injury and albuminuria in diabetic mice. METTL3 modulates Notch signaling through m6A modification of TIMP2, exerting pro-inflammatory and pro-apoptotic effects.

MOLECULAR THERAPY (2022)

Article Chemistry, Medicinal

Eleutheroside B-loaded poly (lactic-co-glycolic acid) nanoparticles protect against renal fibrosis via Smad3-dependent mechanism

Xiaohui Chen, Qixia Liu, Jing Yang, Min Kan, Rui Jin, Tian Pu, Yaru Yang, Tian Xing, Xiaoming Meng, Hongmei Zang

Summary: The study suggests that eleutheroside B may be a potential drug to protect against renal fibrosis, and PLGA-eleutheroside B NPs could facilitate specific targeted therapy for renal fibrosis.

PHYTOTHERAPY RESEARCH (2021)

Review Chemistry, Multidisciplinary

Novel insights into NOD-like receptors in renal diseases

Juan Jin, Tao-jie Zhou, Gui-ling Ren, Liang Cai, Xiao-ming Meng

Summary: NLRs, a major subfamily of pattern recognition receptors, have gained considerable attention due to their involvement in mediating the immune response and inflammatory pathways. This review summarises recent progress on the functions and mechanisms of NLRs in different types of renal diseases.

ACTA PHARMACOLOGICA SINICA (2022)

Article Cell Biology

Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms

Jia-Nan Wang, Fang Wang, Jing Ke, Zeng Li, Chuan-Hui Xu, Qin Yang, Xin Chen, Xiao-Yan He, Yuan He, Xiao-Guo Suo, Chao Li, Ju-Tao Yu, Ling Jiang, Wei-Jian Ni, Juan Jin, Ming-Ming Liu, Wei Shao, Chen Yang, Qian Gong, Hai-Yong Chen, Jun Li, Yong-Gui Wu, Xiao-Ming Meng

Summary: The role of N-6-methyladenosine (m6A) modifications in renal diseases, particularly acute kidney injury (AKI), is still largely unknown. In this study, the researchers investigated the role of N-6-adenosine-methyltransferase-like 3 (METTL3) in AKI and found that its expression is elevated in renal tubules. They discovered that silencing METTL3 alleviated renal inflammation and programmed cell death in tubular epithelial cells (TECs) in response to stimulation, while overexpression of METTL3 had the opposite effects. Conditional knockout of METTL3 in mice also attenuated renal dysfunction, injury, and inflammation induced by AKI. Furthermore, the researchers identified TAB3 as a target of METTL3 and explored its proinflammatory effects. They also investigated the therapeutic potential of inhibiting METTL3 using an inhibitor called Cpd-564. Overall, they concluded that the METTL3/TAB3 axis may be a potential target for the treatment of AKI.

SCIENCE TRANSLATIONAL MEDICINE (2022)

暂无数据